Advanced search
Publication Cover
mAbs Volume 3, 2011 - Issue 2
Submit an article Journal homepage
1,383
Views
19
CrossRef citations to date
0
Altmetric
Meeting Report

IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of The Antibody Society

December 5–9, 2010, San Diego, CA USA

Samantha O Arnett Department of Immunology & Microbial Science and IAVI Neutralizing Antibody Center; The Scripps Research Institute; La Jolla, CA USA
,
Jean-Luc Teillaud Cordeliers Research Center/INSERM U.872; Paris Descartes University and Pierre & Marie Curie University (UPMC); Paris
,
Thierry Wurch Centre d'Immunologie Pierre FABRE; Saint Julien en Genevois; France
,
Janice M ReichertmAbs; Landes Bioscience; Austin, TXCorrespondence[email protected]
,
Cameron Dunlop Department of Immunology & Microbial Science and IAVI Neutralizing Antibody Center; The Scripps Research Institute; La Jolla, CA USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University; Cambridge, MA USA
&
Michael Huber Department of Immunology & Microbial Science and IAVI Neutralizing Antibody Center; The Scripps Research Institute; La Jolla, CA USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University; Cambridge, MA USA
Pages 133-152 | Received 23 Jan 2011, Accepted 23 Jan 2011, Published online: 01 Mar 2011

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Magdalena Malm, Fredrik Y. Frejd, Stefan Ståhl & John Löfblom. (2016) Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds. mAbs 8:7, pages 1195-1209.
Read now
Johan Nilvebrant, D. Cameron Dunlop, Aroop Sircar, Thierry Wurch, Emilia Falkowska, Janice M. Reichert, Gustavo Helguera, Emily C. Piccione, Simon Brack & Sven Berger. (2012) IBC’s 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5–8, 2011, San Diego, CA. mAbs 4:2, pages 153-181.
Read now
Janice M. Reichert. (2012) mAbs’s communication networks. mAbs 4:2, pages 133-133.
Read now
Jeffrey W. Froude, Bradley G. Stiles, Thibaut Pelat & Philippe Thullier. (2011) Antibodies for biodefense. mAbs 3:6, pages 517-527.
Read now

Articles from other publishers (15)

Avisek Majumder. (2023) HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer. Cells 12:21, pages 2517.
Crossref
Yasar Ahmed, Thamir Mahgoub, Maha Al Sindi & José J. Berenguer‐Pina. (2022) New era for emerging therapeutic targeting human epidermal growth factor receptor 3 (HER 3) in advanced nonsmall cell lung cancer and metastatic breast cancer. MedComm – Oncology 1:2.
Crossref
Kimberley M. Heinhuis, Matteo Carlino, Markus Joerger, Massimo Di Nicola, Tarek Meniawy, Sylvie Rottey, Victor Moreno, Anas Gazzah, Jean-Pierre Delord, Luis Paz-Ares, Christian Britschgi, Russell J. Schilder, Kenneth O’Byrne, Giuseppe Curigliano, Emanuela Romano, Poliana Patah, Rui Wang, Yali Liu, Gaurav Bajaj & Lillian L. Siu. (2020) Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor–Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors. JAMA Oncology 6:1, pages 100.
Crossref
Xiaolong Liu, Shuang Liu, Hui Lyu, Adam I. Riker, Yamin Zhang & Bolin Liu. (2019) Development of Effective Therapeutics Targeting HER3 for Cancer Treatment. Biological Procedures Online 21:1.
Crossref
Dang Quan Nguyen, Dinh Hoa Hoang, Thanh Thao Nguyen Vo, Vu Huynh, Lucy Ghoda, Guido Marcucci & Le Xuan Truong Nguyen. (2018) The role of ErbB3 binding protein 1 in cancer: Friend or foe?. Journal of Cellular Physiology 233:12, pages 9110-9120.
Crossref
Hui Lyu, Amy Han, Erik Polsdofer, Shuang Liu & Bolin Liu. (2018) Understanding the biology of HER3 receptor as a therapeutic target in human cancer. Acta Pharmaceutica Sinica B 8:4, pages 503-510.
Crossref
Giulia Bon, Rossella Loria, Carla Azzurra Amoreo, Alessandra Verdina, Isabella Sperduti, Arianna Mastrofrancesco, Silvia Soddu, Maria Grazia Diodoro, Marcella Mottolese, Matilde Todaro, Giorgio Stassi, Michele Milella, Ruggero De Maria & Rita Falcioni. (2016) Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers. Oncotarget 8:65, pages 108463-108479.
Crossref
Nico Jacobi, Rita Seeboeck, Elisabeth Hofmann & Andreas Eger. (2017) ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology. Cancers 9:12, pages 33.
Crossref
Raghav Sundar, Richie Soong, Byoung-Chul Cho, Julie R. Brahmer & Ross A. Soo. (2014) Immunotherapy in the treatment of non-small cell lung cancer. Lung Cancer 85:2, pages 101-109.
Crossref
Meghan M. Morrison, Katherine Hutchinson, Michelle M. Williams, Jamie C. Stanford, Justin M. Balko, Christian Young, Maria G. Kuba, Violeta S?nchez, Andrew J. Williams, Donna J. Hicks, Carlos L. Arteaga, Aleix Prat, Charles M. Perou, H. Shelton Earp, Suleiman Massarweh & Rebecca S. Cook. (2013) ErbB3 downregulation enhances luminal breast tumor response to antiestrogens. Journal of Clinical Investigation 123:10, pages 4329-4343.
Crossref
Nelson S. Yee. 2013. Impact of Genetic Targets on Cancer Therapy. Impact of Genetic Targets on Cancer Therapy 91 143 .
Ning Jiang, Nabil F. Saba & Zhuo Georgia Chen. (2012) Advances in Targeting HER3 as an Anticancer Therapy. Chemotherapy Research and Practice 2012, pages 1-9.
Crossref
Chad May, Puja Sapra & Hans-Peter Gerber. (2012) Advances in bispecific biotherapeutics for the treatment of cancer. Biochemical Pharmacology 84:9, pages 1105-1112.
Crossref
Paul Cornes. (2012) The economic pressures for biosimilar drug use in cancer medicine. Targeted Oncology 7:S1, pages 57-67.
Crossref
P. Cornes. (2011) The economic pressures for biosimilar drug use in cancer medicineLes pressions économiques en faveur de l’utilisation des biosimilaires en oncologie. Oncologie 13:5, pages 222-233.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.